Diastat 25 mg (Tablet)
Unit Price: ৳ 40.00 (10's pack: ৳ 400.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | The white horse pharmaceuticals ltd |
| Also available as |
Title
- Diastat 25 mg Tablet
Categories
- Diabetes Management
- Cardiovascular Health
- Medication
Description
- Diastat is a sodium glucose co-transporter-2 (SGLT-2) inhibitor used to improve glycemic control in adults with type 2 diabetes mellitus.
DosageAndAdministration
- The recommended dose is 10 mg once daily, taken in the morning, with or without food. The dose may be increased to 25 mg once daily in patients tolerating the initial dose.
Pharmacology
- Empagliflozin inhibits SGLT2 co-transporters, leading to increased glucose excretion, reduced hyperglycemia, weight loss, and lowered blood pressure.
Indications
- Adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.
Interaction
- Increased urine volume when co-administered with diuretics
- Increased risk for hypoglycemia when co-administered with insulin or insulin secretagogues
- Inaccurate results in urine glucose tests and interference with 1,5-AG assay when using SGLT2 inhibitors
Contraindications
- History of serious hypersensitivity reaction to Empagliflozin or its ingredients
- Severe renal impairment, end-stage renal disease, or dialysis
SideEffects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
PregnancyAndLactation
- Empagliflozin use during pregnancy only if potential benefit justifies potential risk to fetus
- Not recommended during breastfeeding
PrecautionsAndWarnings
- Assess renal function prior to initiation and periodically thereafter. Do not initiate in patients with an eGFR less than 45 ml/min/1.73 m2. No dose adjustment needed in patients with an eGFR greater than or equal to 45 ml/min/1.73 m2.
OverdoseEffects
- Usual supportive measures should be employed. Hemodialysis study not conducted.
TherapeuticClass
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
StorageConditions
- Store below 30°C, protected from light & moisture, out of reach of children
ChemicalStructure
- Molecular Formula: C23H27ClO7
CommonlyAskedQuestions
- Diastat 25 mg Tablet used to improve glycemic control in adults
- Unsafe during pregnancy
- Probably unsafe during breastfeeding
- Should be used cautiously in patients with underlying kidney disease
- No dose adjustment needed for patients with mild to moderate liver disease
- May cause dehydration and increased urination. Drink plenty of water and stay hydrated.
- May cause hypoglycemia. Always carry sugary food or fruit juice.
- May cause genital fungal and/or urinary tract infections. Practice good hygiene.
- Monitor blood sugar regularly while taking Diastat 25 mg Tablet.
- Inform doctor immediately if experiencing specific symptoms.